Switch to:
More From Other Websites
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 Oct 14 2014
Hyperion, Clal Biotech resolve dispute over diabetes drug Oct 07 2014
Hyperion Therapeutics and Clal Biotechnology Industries Ltd. Enter Into Interim Agreement Oct 07 2014
Ardelyx (ARDX) Worth Watching: Stock Moves 16% Higher Oct 06 2014
NanoViricides, Inc. (NNVC) in Focus: Stock Jumps 9.9% Oct 06 2014
Esperion Therapeutics (ESPR) in Focus: Stock Jumps 5.1% Oct 06 2014
Durata Therapeutics, Inc. (DRTX) Surges: Stock Rises 17.3% Oct 06 2014
Alcobra (ADHD) Crumbles: Stock Falls by 7.4% Oct 06 2014
Zogenix (ZGNX) Shows Strength: Stock Adds 11.2% in Session Oct 06 2014
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 12.4% Oct 06 2014
Radius Health (RDUS) Jumps: Stock Moves 13.9% Higher Sep 29 2014
Cerulean Pharma (CERU) Jumps: Stock Up 9.8% in Session Sep 29 2014
IGI, Laboratories (IG) Jumps: Stock Up 18.1% in Session Sep 26 2014
Esperion Therapeutics (ESPR) in Focus: Stock Up 13.4% Sep 25 2014
Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% Sep 25 2014
Hyperion Therapeutics to Present at the Leerink Rare Disease Roundtable Sep 24 2014
Salix Pharmaceuticals (SLXP) in Focus: Stock Up 5.8% Sep 24 2014
Radius Health (RDUS) in Focus: Stock Surges 17.3% Sep 24 2014
Hyperion Therapeutics to Host Analyst Day September 30, 2014 Sep 23 2014
Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Sep 19 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK